Erlangen

Corindus Announces Global Launch of technIQ™1 Smart Procedural Automation Series for CorPath® GRX System

Retrieved on: 
Tuesday, December 15, 2020

Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today the global launch of a new set of automated robotic movements in the technIQ Series designed for the CorPath GRX System.

Key Points: 
  • Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today the global launch of a new set of automated robotic movements in the technIQ Series designed for the CorPath GRX System.
  • In 2018, Corindus received CE Mark and FDA clearance for an automated technique called Rotate on Retract (RoR).
  • RoR was the first automated robotic movement in the technIQ Series and has demonstrated the potential to significantly reduce wiring time.
  • To learn more about Corindus and CorPath GRX, please visit www.corindus.com .

CORVENT MEDICAL ANNOUNCES STRATEGIC PARTNERSHIP WITH SIEMENS HEALTHINEERS FOR DISTRIBTUION OF THE RESPOND-19™ VENTILATOR

Retrieved on: 
Tuesday, December 15, 2020

We are excited to work with the CorVent team and anticipate a fruitful partnership that fills an ongoing market need."

Key Points: 
  • We are excited to work with the CorVent team and anticipate a fruitful partnership that fills an ongoing market need."
  • Earlier this month, CorVent received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the RESPOND-19 Ventilator.
  • CorVent Medical, a privately held portfolio company of medtech incubator Coridea LLC , is committed to developing smart, versatile, lifesaving ventilators for critical care.
  • Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients.

Global Digital X-ray Market Outlook 2020-2025 Featuring Prominent Vendors - Siemens Healthineers, GE Healthcare, Koninklijke Philips, Canon Medical Systems, Fujifilm, Carestream Health - ResearchAndMarkets.com

Retrieved on: 
Friday, November 13, 2020

The global digital x-ray market by revenue is expected to grow at a CAGR of over 7% during the period 2019-2025.

Key Points: 
  • The global digital x-ray market by revenue is expected to grow at a CAGR of over 7% during the period 2019-2025.
  • The global digital x-ray devices market research report includes a detailed segmentation by application, portability, end-user, geography.
  • Siemens Healthineers, GE Healthcare, Koninklijke Philips, Canon Medical Systems, Fujifilm, and Carestream Health have demonstrated consistent growth over the last few years.
  • Moderate to high growth of major players will continue to boost the global market growth for digital X-ray devices.

Global Breast Imaging Market Report 2020-2025 Featuring Hologic, GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm, Canon, Aurora Healthcare US, and CMR Naviscan - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 3, 2020

The "Global Breast Imaging Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Breast Imaging Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • Key factors such as increasing incidence of breast cancer coupled with the growing awareness about early detection of breast cancer is anticipated to drive the Global Breast Imaging market in the forecast period.
  • Breast Imaging involves various types of imaging procedures to have a better understanding of breast related ailments.
  • Some of the companies covered in this report are Hologic, Inc., GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Aurora Healthcare US Corp., and CMR Naviscan Corporation

Siemens Healthineers Makes Major Donation of Imaging and Clinical Laboratory Equipment to Medisend College in support of General Richard B Myers Veterans Program

Retrieved on: 
Thursday, October 29, 2020

DALLAS, Oct. 29, 2020 /PRNewswire-PRWeb/ -- Siemens Healthineers has donated new X-ray, ultrasound and clinical laboratory equipment, valued at more than $1,000,000, to Medisend College of Biomedical Engineering Technology to help advance the education and training of US military veterans in the General Richard B Myers Veterans Program.

Key Points: 
  • DALLAS, Oct. 29, 2020 /PRNewswire-PRWeb/ -- Siemens Healthineers has donated new X-ray, ultrasound and clinical laboratory equipment, valued at more than $1,000,000, to Medisend College of Biomedical Engineering Technology to help advance the education and training of US military veterans in the General Richard B Myers Veterans Program.
  • The equipment donated by Siemens Healthineers will be housed in the new Touchstone Imaging Laboratories at Medisend College where students will benefit from the latest imaging technologies.
  • "Siemens Healthineers enables healthcare providers by empowering them on their journey towards expanding precision medicine.
  • Medisend College has been training veterans and successfully placing them in positions with major healthcare organizations since 2013.

CT Scanner Market Revenue to Cross USD 8.7 Bn by 2026: Global Market Insights, Inc.

Retrieved on: 
Thursday, October 29, 2020

The C-arm segment in the CT scanner market will witness growth of over 6% till 2026.

Key Points: 
  • The C-arm segment in the CT scanner market will witness growth of over 6% till 2026.
  • The veterinary application in the CT scanner market is estimated to attain a CAGR of 5% through 2026.
  • Thus, multifactorial benefits delivered by CT scanner in early as well as later stages of clinical trials will boostindustry revenue.
  • Some of the prominent market players in the CT scanner market include Accuray, CurveBeam, Carestream, Medtronic, Philips, Hitachi Medical, Canon Medical Systems, Koning, Neusoft, Siemens Healthineers, GE Healthcare, and others.

Siemens Healthineers and WakeMed Announce Innovative Relationship to Advance Care and Improve Outcomes

Retrieved on: 
Wednesday, September 30, 2020

Siemens Healthineers and WakeMed Health & Hospitals have established a 10-year, patient-focused, Value Partnership to innovate care delivery and improve patient outcomes through robotics initiatives, advanced imaging capabilities and artificial intelligence, along with provider and staff training.

Key Points: 
  • Siemens Healthineers and WakeMed Health & Hospitals have established a 10-year, patient-focused, Value Partnership to innovate care delivery and improve patient outcomes through robotics initiatives, advanced imaging capabilities and artificial intelligence, along with provider and staff training.
  • WakeMed and Siemens Healthineers will also form a Corindus Training Academy a workforce development program and training site for advanced imaging and robotic intervention innovations.
  • The opportunity to launch a biomedical workforce development program incorporating WakeMed and Siemens Healthineers employees will allow for constant resource development and advanced training.
  • Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients.

Babson Diagnostics Appoints Former Siemens Healthineers Executive to CEO

Retrieved on: 
Thursday, September 24, 2020

Babson Diagnostics (Babson), a transformative medical technology company, has appointed David Stein, Ph.D., former head of global strategy and innovation at Siemens Healthineers, to chief executive officer.

Key Points: 
  • Babson Diagnostics (Babson), a transformative medical technology company, has appointed David Stein, Ph.D., former head of global strategy and innovation at Siemens Healthineers, to chief executive officer.
  • His prior roles include head of strategy and innovation for Siemens Healthineers, CEO of Siemens' point of care businesses, and global vice president of engineering within Siemens diagnostics division.
  • Eric and the Babson Diagnostics team have built a truly unique diagnostics model underpinned by the worlds leaders in health care innovation, Dr. Stein said.
  • Prior to commercialization, Babson Diagnostics is working with retail pharmacies to validate its technology by conducting clinical studies intended for peer-reviewed publication.

Babson Diagnostics Closes $13.7 Million Series A to Democratize Diagnostic Blood Testing

Retrieved on: 
Thursday, September 24, 2020

Babson Diagnostics (Babson), a transformative medical technology company, announced today it closed $13.7 million in cumulative Series A funding, led by Siemens Healthineers, Prism Ventures, Genesis Merchant Capital, and Lago Consulting Group.

Key Points: 
  • Babson Diagnostics (Babson), a transformative medical technology company, announced today it closed $13.7 million in cumulative Series A funding, led by Siemens Healthineers, Prism Ventures, Genesis Merchant Capital, and Lago Consulting Group.
  • Babson Diagnostics was incubated from its earliest days within Siemens Healthineers, said Dr. Deepak Nath, president of laboratory diagnostics for Siemens Healthineers.
  • The company continues to make great progress in democratizing diagnostic blood testing and in contributing to the U.S.s fight against the COVID-19 pandemic.
  • Babson Diagnostics aims to democratize diagnostic blood testing by making it easier, faster, and more pleasant for customers to routinely monitor and improve their health.

Siemens Healthineers Announces Collaboration Agreement for Assay Development With an Initial Focus on Multiple Sclerosis

Retrieved on: 
Monday, September 21, 2020

The initial program assists the development of a serum NfL immunoassay to support Novartis MS and other neuroscience programs.

Key Points: 
  • The initial program assists the development of a serum NfL immunoassay to support Novartis MS and other neuroscience programs.
  • This collaboration will leverage Siemens Healthineers expertise in the development of innovative clinical diagnostic solutions that can run on Siemens Healthineers global population of ADVIA Centaur and Atellica immunoassay platforms designed for use in hospitals, reference laboratories, and specialty laboratories.
  • Our initial focus on blood-based diagnostic solutions for MS patients is another example of Siemens Healthineers commitment to shape the future of precision medicine.
  • The Siemens Healthineers AB42 and Tau assays were recently granted FDA Breakthrough Device Designation for expedited reviews.